NOVOSEVEN 1 mg (50 KUI) POWDER AND SOLVENT FOR INJECTABLE SOLUTION

Ask a doctor about a prescription for NOVOSEVEN 1 mg (50 KUI) POWDER AND SOLVENT FOR INJECTABLE SOLUTION

0.0(0)

Tomasz Grzelewski

Dermatology20 years of experience

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

seasonal and perennial allergies
allergic rhinitis and chronic nasal symptoms
asthma and breathing difficulties
food and medication allergies
urticaria, atopic dermatitis and skin reactions
recurrent infections in children
sports-related health questions
general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Book a video appointment

Antonio Cayatte

General medicine43 years of experience

Dr Antonio Cayatte is a physician in General and Acute Medicine with over 30 years of experience across clinical care, medical research, and education. He offers online consultations for adults with a wide range of symptoms, both acute and chronic.

His clinical background includes:

assessment of sudden or unclear symptoms
ongoing care for chronic conditions
follow-up after hospital discharge
interpretation of test results
medical support while abroad

Dr Cayatte earned his degree from the University of Lisbon and taught internal medicine at Boston University School of Medicine. He holds active medical registrations in both Portugal and the UK and is a Fellow of the American Heart Association.

Consultations are available in English and Portuguese. Patients value his clarity, professionalism, and balanced approach to evidence-based care.

Book a video appointment

Tomasz Grzelewski

Dermatology20 years of experience

Patients commonly seek his care for:

seasonal and perennial allergies
allergic rhinitis and chronic nasal symptoms
asthma and breathing difficulties
food and medication allergies
urticaria, atopic dermatitis and skin reactions
recurrent infections in children
sports-related health questions
general family medicine concerns

Book a video appointment

Antonio Cayatte

General medicine43 years of experience

His clinical background includes:

assessment of sudden or unclear symptoms
ongoing care for chronic conditions
follow-up after hospital discharge
interpretation of test results
medical support while abroad

Consultations are available in English and Portuguese. Patients value his clarity, professionalism, and balanced approach to evidence-based care.

Book a video appointment

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.

How to use NOVOSEVEN 1 mg (50 KUI) POWDER AND SOLVENT FOR INJECTABLE SOLUTION

Introduction

Package Leaflet: Information for the User

NovoSeven 1mg (50KUI) powder and solvent for solution for injection

NovoSeven 2mg (100KUI) powder and solvent for solution for injection

NovoSeven 5mg (250KUI) powder and solvent for solution for injection

NovoSeven 8mg (400KUI) powder and solvent for solution for injection

eptacog alfa (activated)

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

Keep this leaflet, you may need to read it again.
If you have any further questions, ask your doctor.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

What is NovoSeven and what is it used for
What you need to know before you use NovoSeven
How to use NovoSeven
Possible side effects
Storage of NovoSeven
Contents of the pack and further information

On the back: Instructions for use of NovoSeven

1. What is NovoSeven and what is it used for

NovoSeven is a blood clotting factor. It works by activating the blood clotting system at the site of bleeding when the patient's own clotting factors are not working.

NovoSeven is used to treat bleeding and to prevent excessive bleeding after surgery or other major treatments. Early treatment with NovoSeven reduces the amount and duration of bleeding. It works in all types of bleeding, including joint bleeding. This reduces the need for hospitalization and days off work or school.

It is used in certain groups of people:

If you have congenital hemophilia and do not respond normally to treatment with factors VIII or IX
If you have acquired hemophilia
If you have Factor VII deficiency
If you have Glanzmann's thrombasthenia (a bleeding disorder) and your disease cannot be effectively treated with platelet transfusion, or if platelets are not readily available.

NovoSeven may also be given to you by a doctor to treat heavy bleeding after childbirth, even if you do not have a bleeding disorder.

2. What you need to know before you use NovoSeven

Do not use NovoSeven

If you are allergic to eptacog alfa (the active substance of NovoSeven) or to any of the other ingredients of this medicine (listed in section 6).
If you are allergic to mouse, hamster or bovine proteins (such as cow's milk).

If any of these apply to you, do not use NovoSeven. Talk to your doctor.

Warnings and precautions

Before starting treatment with NovoSeven, make sure your doctor knows:

If you have recently undergone surgery
If you have recently suffered a crush injury
If your arteries are narrower due to disease (atherosclerosis)
If you have a higher risk of blood clot formation (thrombosis)
If you have severe liver disease
If you have severe septicemia
If you are prone to disseminated intravascular coagulation (DIC, a condition in which blood clots form in the bloodstream) you should be closely monitored.

If any of these apply to you, tell your doctor before using this product.

Other medicines and NovoSeven

Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.

Do not use NovoSeven at the same time as prothrombin complex concentratesor rFXIII. You should consult your doctor before using NovoSeven if you are also using factor VIII or IX.

There is limited experience with the use of NovoSeven together with other medicines called antifibrinolytics (such as aminocaproic acid or tranexamic acid) which are also used to control bleeding. You should consult your doctor before using NovoSeven with these medicines.

Pregnancy, breastfeeding and fertility

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using NovoSeven.

Driving and using machines

There are no studies on the effects of NovoSeven on the ability to drive and use machines. However, there is no medical reason to think that it could affect your ability.

NovoSeven contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per injection, which is essentially "sodium-free".

3. How to use NovoSeven

NovoSeven powder must be reconstituted with the solvent and injected intravenously. See the detailed instructions on the back.

When to treat

Start treatment of a bleed as soon as possible, ideally within the first 2 hours.

In case of a mild or moderate bleed, you should treat yourself as soon as possible, preferably at home.
In case of a severe bleed, you should contact your doctor. Normally, severe bleeds are treated in hospital and you can give yourself the first dose of NovoSeven on the way there.

You should not treat for more than 24 hours without consulting your doctor.

Each time you use NovoSeven, you should inform your doctor or hospital as soon as possible.
If the bleed is not controlled within the first 24 hours, contact your doctor immediately. You will usually need hospital attention.

Dose

The first dose should be given as soon as possible after the start of the bleed. Ask your doctor when injections should be given and how long you should continue using them.

Your doctor will decide your dose, based on your body weight, condition and type of bleed.

To get the best result, follow the prescribed dose carefully. Your doctor may change the dose.

If you have hemophilia:

The normal dose is 90 micrograms per kilogram of body weight; you can repeat the injection every 2-3 hours until the bleed is controlled.

Your doctor may recommend a single dose of 270 micrograms per kilogram of body weight. There is no clinical experience with this single dose in people over 65 years of age.

If you have Factor VII deficiency:

The normal dose range is 15-30 micrograms per kilogram of body weight, for each injection.

If you have Glanzmann's thrombasthenia:

The usual dose is 90 micrograms (range 80 to 120 micrograms) per kilogram of body weight, for each injection.

If you inject more NovoSeven than you should

If you inject too much NovoSeven, talk to a doctor immediately.

If you forget to inject a dose of NovoSeven

If you forget to inject a dose of NovoSeven or want to stop treatment, talk to a doctor immediately.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Serious side effects

Rare (may affect up to 1 in 1,000 people treated)

Allergic reactions, hypersensitivity or anaphylactic reactions. Symptoms may include skin rash, itching, redness and hives; chest tightness or difficulty breathing; dizziness or lightheadedness, and severe swelling of the lips or throat, or at the injection site.
Blood clots in the arteries of the heart (which could lead to a heart attack or angina), in the brain (which could lead to a stroke), or in the intestine and kidneys. Symptoms may include severe chest pain, difficulty breathing, confusion, difficulty with speech or movement (paralysis), or abdominal pain.

Uncommon (may affect up to 1 in 100 people treated)

Blood clots in the veins of the lungs, legs, liver, kidneys, or at the injection site. Symptoms may include difficulty breathing, red and painful swelling of the leg, and abdominal pain.
Lack of efficacy or reduced response to treatment.

If you experience any of these serious side effects, seek medical help immediately. Tell your doctor that you have been using NovoSeven.

Remember to tell your doctor if you have a history of allergic reactions, as you may need closer monitoring. In the vast majority of reported cases of thrombosis, patients had a predisposition to thrombotic disorders.

Other rare side effects

(may affect up to 1 in 1,000 people treated)

Nausea (feeling sick)
Headache
Changes in some blood test and liver results.

Other uncommon side effects

(may affect up to 1 in 100 people treated)

Skin rash, including rash, itching, and hives
Fever.

Reporting of side effects

If you experience any side effects, talk to your doctor, even if they are not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of NovoSeven

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date is the last day of the month stated.
Store the powder and solvent below 25°C.
Store the powder and solvent protected from light.
Do not freeze.
Use NovoSeven immediately after mixing the powder with the solvent to avoid infections. If you cannot use it immediately, after mixing, you should store it in the vial with the vial adapter and with the syringe still in place, in the refrigerator between 2°C and 8°C, for a maximum of 24 hours. Do not freeze the reconstituted NovoSeven solution and keep it protected from light. Do not store the solution without consulting your doctor or nurse.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Container Contents and Additional Information

Composition of NovoSeven

The active substance is recombinant coagulation factor VIIa (eptacog alfa activated).
The other components in the powder are sodium chloride, calcium chloride dihydrate, glycylglycine, polysorbate 80, mannitol, sucrose, methionine, hydrochloric acid, and sodium hydroxide. The components of the solvent are histidine, hydrochloric acid, sodium hydroxide, and water for injections.

The powder for solution for injection contains: 1 mg/vial (which corresponds to 50 KUI/vial), 2 mg/vial (which corresponds to 100 KUI/vial), 5 mg/vial (which corresponds to 250 KUI/vial), or 8 mg/vial (which corresponds to 400 KUI/vial).

After reconstitution, 1 ml of the solution contains 1 mg of eptacog alfa (activated).

1 KUI is equal to 1,000 IU (International Units).

Appearance of NovoSeven and Container Contents

The vial of powder contains white powder and the pre-filled syringe contains a clear and colorless solution. The reconstituted solution is colorless. Do not use the reconstituted solution if particles appear or if it is discolored.

Each NovoSeven container contains:

1 vial with white powder for solution for injection
1 vial adapter
1 pre-filled syringe with solvent for reconstitution
1 plunger

Presentation: 1 mg (50 KUI), 2 mg (100 KUI), 5 mg (250 KUI), and 8 mg (400 KUI).

The current presentation is indicated on the outer packaging.

Marketing Authorization Holder and Manufacturer

Novo Nordisk A/S

Novo Allé

DK-2880 Bagsværd, Denmark

Date of Last Revision of this Leaflet:

Other Sources of Information

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu.

Instructions for Use of NovoSeven

READ THESE INSTRUCTIONS CAREFULLY BEFORE USING NOVOSEVEN

NovoSeven is presented as a powder. Before injection (administration), it must be reconstituted with the solvent that accompanies it in the syringe. The solvent is a histidine solution. The reconstitution of NovoSeven must be injected into a vein (intravenous injection). The equipment in this container is designed to reconstitute and inject NovoSeven.

You will also need administration equipment (catheter and butterfly needle, sterile alcohol-impregnated swabs, gauze pads, and adhesive strips). These materials are not included in the NovoSeven container.

Do not use the equipment without proper training by your doctor or nurse.

Always wash your hands and ensure the area around you is clean.

When preparing and injecting a medication directly into a vein, it is essential to use a clean and germ-free technique (aseptic technique).An inappropriate technique can introduce germs capable of infecting the blood.

Do not open the equipment until you are ready to use it.

Do not use the equipment if it has been dropped or is damaged.In that case, use a new container.

Do not use the equipment if it has expired.In that case, use a new container. The expiration date is printed after EXP on the carton, vial, vial adapter, and pre-filled syringe.

Do not use the equipment if you suspect it is contaminated.In that case, use a new container.

Do not discard any of the materials until the reconstituted solution has been injected.

The equipment is for single use.

Contents

The container contains:

1 vial with NovoSeven powder
1 vial adapter
1 pre-filled syringe with solvent
1 plunger (located under the syringe)

Glass vial with white powder, rubber stopper covered by a light blue plastic cap

Vial adapter with transparent protective cap and visible spike under paper protector

Pre-filled syringe with solvent showing cap, tip, piston, and graduated scale on cylindrical body

Diagram of a plunger with thread on one end and wide opposite end, arrows indicate parts

Prepare the vial and syringe

Remove the number of NovoSeven containers you will need.

Check the expiration date.

Check the name, concentration, and color of the container to ensure it contains the correct product.

Wash your hands and dry them well with a clean towel or dry air.

Remove the vial, vial adapter, and pre-filled syringe from the container. Leave the plunger untouched in the container.

Bring the vial and pre-filled syringe to room temperature (not above 37°C). You can do this by holding them in your hands until you feel they are at the same temperature as your hands.

Do not use any other system to heat the vial and pre-filled syringe.

Two hands holding ends of a white and purple medical device for connection

Remove the plastic cap from the vial.

If the plastic cap is loose or missing, do not use the vial.

Clean the rubber stopper with an alcohol-impregnated swab and let it air dry for a few seconds before use to ensure it is as germ-free as possible.

Do not touch the rubber stopper with your fingers, as this can transfer germs.

Hand holding a blue medicine vial with a silver cap about to be removed by a blue arrow

Place the vial adapter

Remove the paper seal from the vial adapter.

If the paper seal is not completely sealed or is broken, do not use the vial adapter.

Do not remove the vial adapter from the protective cap with your fingers.If you touch the spike of the vial adapter, you can transfer germs from your fingers.

Hands holding a pre-filled syringe with needle pointing up and arrow indicating injection direction

Place the vial on a flat and solid surface.

Turn the protective cap over and fit the vial adapter onto the vial.

Once joined, do not remove the vial adapter from the vial.

Hand pressing an auto-injector device onto the skin with a medicine vial underneath

Gently press the protective cap between your thumb and index finger as shown in the drawing.

Remove the protective capfrom the vial adapter.

Do not remove the vial adapter from the vialwhen removing the protective cap.

Hand holding an application device with a blue arrow indicating direction and small vial in the lower right corner

Place the plunger on the syringe.

Hold the plunger by the wide end and remove it from the container. Do not touch the sides or thread of the plunger. If you touch the sides or thread, you can transfer germs from your fingers.

Connect the plunger immediatelyto the syringe by turning it clockwise in the piston inside the pre-filled syringe until you feel resistance.

Hands holding a pre-filled injection device with an arrow indicating activation direction

Remove the syringe cap from the pre-filled syringe by folding it down until the perforation breaks.

Do not touch the tip of the syringe under the syringe cap.If you touch the tip of the syringe, you can transfer germs from your fingers.

If the syringe cap is loose or missing, do not use the pre-filled syringe.

Hands holding an insulin applicator and a puncture needle with an arrow indicating connection

Tightly screw the pre-filled syringe onto the vial adapter until you feel resistance.

Hands holding an auto-injector with an arrow indicating device removal direction

Reconstitute the powder with the solvent

Hold the pre-filled syringe slightly inclined with the vial facing down.

Press the plunger to inject all the solvent into the vial.

Hand holding a syringe with a needle inserted into the skin, blue arrow indicates subcutaneous injection direction

Keep the plunger pressed and make gentle circular movements with the vial until all the powder is dissolved.

Do not shake the vial, as this can produce foam.

Check the reconstituted solution. It should be colorless. If you see particles or a color change, do not use it. In that case, use a new container.

Hand holding an auto-injector with a small vial attached, turning clockwise with an arrow indicating direction

Use the reconstituted NovoSeven immediatelyto avoid infections.

If you cannot use it immediately,see section 5Storage of NovoSevenon the other side of this leaflet. Do not store the reconstituted solution without consulting your doctor or nurse.

(I)

If your dose requires more than one vial, repeat steps Ato Jwith additional vials, vial adapters, and pre-filled syringes until you reach the required dose.

Keep the plunger fully pressed.

Turn the syringe over with the vial facing down.

Release the pressure on the plunger and let it slide down by itself while the reconstituted solution passes into the syringe.

Pull the plunger down slightly to transfer all the reconstituted solution to the syringe.

If you do not need the full dose, use the scale on the syringe to see how much reconstituted solution to extract, as your doctor or nurse has taught you.

If there is too much air in the syringe at any time, reinject the air into the vial.

While holding the vial upside down, gently tap the syringe to make the air bubbles rise.

Slowly press the plunger until no air bubbles remain.

Hand holding a pre-filled syringe with transparent medication and black plunger, arrow indicates downward pressure

Unscrew the vial adapter with the vial.

Do not touch the tip of the syringe. If you touch the tip of the syringe, you can transfer germs from your fingers.

Hand holding an auto-injector with a removed needle protector showing the connection mechanism to a transparent ampoule

Injection of NovoSeven with pre-filled syringe through needle-free connectors for intravenous (IV) catheters

Precaution:The pre-filled syringe is made of glass and is designed to be compatible with standard luer-lock connections. Some needle-free connectors with an internal spike are incompatible with the pre-filled syringe. This incompatibility can prevent medication administration and/or damage the needle-free connector.

Follow the instructions for use of the needle-free connector. Administration through a needle-free connector may require extracting the reconstituted solution with a standard 10 ml sterile luer-lock plastic syringe. This should be done immediately after step J.

Inject the reconstituted solution

NovoSeven is now ready to be injected into a vein.

Inject the reconstituted solution according to the instructions of your doctor or nurse.

Inject slowly over 2 to 5 minutes.

Injection through a central venous access device (CVAD) such as a central venous catheter or subcutaneous port:

Use a clean and germ-free technique (aseptic technique). Follow the instructions for the proper use of your connector and CVAD with the guidance of your doctor or nurse.
Injection into a CVAD may require using a 10 ml sterile plastic syringe to extract the reconstituted solution.
If it is necessary to flush the CVAD line before or after the injection of NovoSeven, use sodium chloride 9 mg/ml solution for injection.

Disposal

After injection, safely discard the syringe with the administration equipment, the vial with the vial adapter, the unused NovoSeven, and other waste according to the instructions of your doctor or nurse.

Do not throw it away with household waste.

Vial with gray cap, needle connected to a cylinder, and small vial with white powder, arrow indicates direction

Do not disassemble the equipment before discarding it.

Do not reuse the equipment.

Country of registration
Spain
Active substance
coagulation factor VIIa
Prescription required
Yes
Manufacturer
Novo Nordisk A/S
This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
Alternatives to NOVOSEVEN 1 mg (50 KUI) POWDER AND SOLVENT FOR INJECTABLE SOLUTION
CEVENFACTA 1 mg (45 KIU) POWDER AND SOLVENT FOR INJECTABLE SOLUTION
Dosage form: INJECTABLE, 1 mg (45 kIU)
Active substance: coagulation factor VIIa
Manufacturer: Laboratoire Francais Du Fractionnement Et Des Biotechnologies
Prescription required
CEVENFACTA 2 MG (90 KIU) POWDER AND SOLVENT FOR INJECTABLE SOLUTION
Dosage form: INJECTABLE, 2 mg (90 kIU)
Active substance: coagulation factor VIIa
Manufacturer: Laboratoire Francais Du Fractionnement Et Des Biotechnologies
Prescription required
CEVENFACTA 5 MG (225 KIU) POWDER AND SOLVENT FOR INJECTABLE SOLUTION
Dosage form: INJECTABLE, 5 mg (225 kIU)
Active substance: coagulation factor VIIa
Manufacturer: Laboratoire Francais Du Fractionnement Et Des Biotechnologies
Prescription required

Alternatives to NOVOSEVEN 1 mg (50 KUI) POWDER AND SOLVENT FOR INJECTABLE SOLUTION in other countries

The best alternatives with the same active ingredient and therapeutic effect.

Alternative to NOVOSEVEN 1 mg (50 KUI) POWDER AND SOLVENT FOR INJECTABLE SOLUTION in Украина

НОВОСЕВЕН

Dosage form: порошок, по 5 мг (250 МЕ) 1 стеклянный флакон

Active substance: coagulation factor VIIa

Manufacturer: A/T Novo Nordisk

Prescription required

НОВОСЕВЕН

Dosage form: порошок, 2 мг (100 МЕ)

Active substance: coagulation factor VIIa

Manufacturer: A/T Novo Nordisk

Prescription required

Online doctors for NOVOSEVEN 1 mg (50 KUI) POWDER AND SOLVENT FOR INJECTABLE SOLUTION

Discuss dosage, side effects, interactions, contraindications, and prescription renewal for NOVOSEVEN 1 mg (50 KUI) POWDER AND SOLVENT FOR INJECTABLE SOLUTION – subject to medical assessment and local rules.

0.0(0)

Tomasz Grzelewski

Dermatology20 years of experience

Patients commonly seek his care for:

seasonal and perennial allergies
allergic rhinitis and chronic nasal symptoms
asthma and breathing difficulties
food and medication allergies
urticaria, atopic dermatitis and skin reactions
recurrent infections in children
sports-related health questions
general family medicine concerns

Book a video appointment

Antonio Cayatte

General medicine43 years of experience

His clinical background includes:

assessment of sudden or unclear symptoms
ongoing care for chronic conditions
follow-up after hospital discharge
interpretation of test results
medical support while abroad

Consultations are available in English and Portuguese. Patients value his clarity, professionalism, and balanced approach to evidence-based care.

Book a video appointment

Jonathan Marshall Ben Ami

Family medicine8 years of experience

Dr. Jonathan Marshall Ben Ami is a licensed family medicine doctor in Spain. He provides comprehensive care for adults and children, combining general medicine with emergency care expertise to address both acute and chronic health concerns.

Dr. Ben Ami offers expert diagnosis, treatment, and follow-up for:

Respiratory infections (cold, flu, bronchitis, pneumonia).
ENT conditions such as sinusitis, ear infections, and tonsillitis.
Digestive issues including gastritis, acid reflux, and irritable bowel syndrome (IBS).
Urinary tract infections and other common infections.
Management of chronic diseases: high blood pressure, diabetes, thyroid disorders.
Acute conditions requiring urgent medical attention.
Headaches, migraines, and minor injuries.
Wound care, health check-ups, and ongoing prescriptions.

With a patient-focused and evidence-based approach, Dr. Ben Ami supports individuals at all stages of life — offering clear medical guidance, timely interventions, and continuity of care.

Book a video appointment

Andrei Popov

General medicine6 years of experience

Dr. Andrei Popov is a licensed pain management specialist and general practitioner based in Spain. He provides expert online care for adults dealing with both chronic and acute pain, as well as a wide range of everyday health concerns.

He specialises in diagnosing and treating pain conditions that affect quality of life, including:

Chronic pain lasting more than 3 months.
Migraines and recurring headaches.
Neck, back, lower back, and joint pain.
Post-traumatic pain following injury or surgery.
Nerve-related pain, fibromyalgia, and neuralgia.

In addition to pain management, Dr. Popov helps patients with:

Respiratory infections (colds, bronchitis, pneumonia).
High blood pressure and metabolic conditions such as diabetes.
Preventive care and routine health check-ups.

Online consultations last up to 30 minutes and include a detailed symptom review, personalised treatment planning, and medical follow-up when needed.

Dr. Popov’s approach is rooted in evidence-based medicine, combined with individualised care tailored to each patient’s history, lifestyle, and clinical needs.

Book a video appointment

Tetiana Fedoryshyn

General medicine29 years of experience

Dr Tetiana Fedoryshyn is a senior general practitioner, certified nutritionist, and psychologist with over 29 years of clinical experience. She combines classical internal medicine with modern approaches in lifestyle medicine, functional nutrition, and emotional health support.

Her focus is on helping patients regain health through deep understanding of symptoms, personalised nutrition plans, and evidence-based correction of deficiencies, stress-related conditions, and metabolic imbalances. Dr Fedoryshyn works with adults experiencing chronic conditions, fatigue, hormonal disruption, and post-stress exhaustion.

She integrates medical analysis, psychological insight, and real-life behaviour change tools to offer treatment plans tailored to each patient’s biochemistry, mental state, and lifestyle.

Main areas of practice:

Chronic condition management and medical counselling
Weight loss programmes based on metabolic profiling
Diagnosis and treatment of micronutrient deficiencies
Recovery from stress, burnout, and hormonal imbalances
Emotional support and psychosomatic symptom care

Her approach is never one-size-fits-all – each consultation begins with a deep dive into your unique health history, test results, and emotional landscape. Consultations are available in Ukrainian, Polish, and Russian.

Book a video appointment

Anna Biriukova

General medicine5 years of experience

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
Leg swelling, chronic fatigue, reduced exercise tolerance.
EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
Post-COVID-19 cardiac monitoring and care.

Endocrinology – Diabetes, thyroid, metabolism:

Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
Individual treatment plans including oral medications and insulin therapy.
GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
Metabolic syndrome – obesity, lipid disorders, insulin resistance.

Gastroenterology – Digestive health:

Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).

General internal medicine and preventive care:

Respiratory infections – cough, colds, bronchitis.
Lab test analysis, therapy adjustments, medication management.
Adult vaccinations – planning, contraindications assessment.
Cancer prevention – screening strategies and risk assessment.
Holistic approach – symptom relief, complication prevention, and quality of life improvement.

Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.

Book a video appointment

Maryna Kuznetsova

Cardiology16 years of experience

Dr Marina Kuznetsova is an internal medicine doctor and cardiologist with a PhD in medicine. She provides online consultations for adults with chronic and acute conditions, with a strong focus on cardiovascular health. Her approach is based on current clinical guidelines and evidence-based treatment strategies.

Areas of expertise:

dyslipidaemia and lipid metabolism disorders
prevention and management of atherosclerosis
blood pressure monitoring and antihypertensive therapy
arrhythmias: diagnosis, follow-up, and treatment adjustment
cardiovascular care and recovery support after Covid-19

Dr Kuznetsova helps patients manage cardiovascular risk factors, optimise long-term treatment, and gain clarity in complex health situations – all through accessible and structured online care.

Book a video appointment

Dmytro Horobets

Family medicine6 years of experience

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Book a video appointment

Karim BenHarbi

General medicine8 years of experience

Dr. Karim Ben Harbi is a licensed general practitioner based in Italy. He provides online consultations for adults and children, combining international clinical experience with evidence-based medicine. His care approach is focused on accurate diagnosis, preventive care, and personalised health guidance.

Dr. Ben Harbi received his medical degree from Sapienza University in Rome. His training included hands-on experience in diverse settings — tropical medicine, rural healthcare, and urban outpatient practice. He also conducted clinical research in microbiology, exploring the role of the gut microbiome in chronic gastrointestinal issues.

You can consult Dr. Ben Harbi for:

General health concerns, prevention, and primary care.
Hypertension, type 1 and type 2 diabetes, metabolic issues.
Cold, cough, flu, respiratory infections, sore throat, fever.
Chronic digestive issues: bloating, gastritis, IBS, microbiome imbalance.
Skin rashes, mild allergic reactions, basic dermatological complaints.
Medication guidance, treatment adjustments, prescription review.
Paediatric concerns — fever, infections, general well-being.
Lifestyle optimisation: stress, sleep, weight, and diet counselling.

Dr. Ben Harbi offers reliable, accessible medical support through online consultations, helping patients make informed decisions about their health with a clear, structured, and compassionate approach.

Book a video appointment

Svetlana Kolomeeva

Cardiology17 years of experience

Dr. Svetlana Kolomeeva is a general practitioner and internal medicine doctor providing online consultations for adults. She helps patients manage acute symptoms, chronic conditions, and preventive care. Her clinical focus includes cardiovascular health, hypertension control, and managing symptoms like fatigue, weakness, sleep issues, and overall low energy.

Patients commonly seek her help for:

High blood pressure, headaches, dizziness, swelling, palpitations.
Diagnosis and management of hypertension, arrhythmias, and tachycardia.
Metabolic syndrome, excess weight, high cholesterol.
Chronic fatigue, insomnia, poor concentration, anxiety.
Respiratory symptoms: colds, flu, sore throat, cough, fever.
Digestive issues: heartburn, bloating, constipation, IBS symptoms.
Chronic conditions: diabetes, thyroid disorders.
Interpretation of lab tests and medical reports, therapy adjustment.
Second opinion and decision-making support.
Cardiovascular disease prevention and metabolic risk reduction.
Long-term follow-up and dynamic health monitoring.

Dr Kolomeeva combines clinical expertise with personalised care. She clearly explains diagnoses, guides patients through symptoms and treatment options, and provides actionable plans. Her consultations are designed not only to address current complaints but also to stabilise chronic conditions and prevent future complications. She supports patients through every stage of care – from first symptoms to ongoing health management.

Book a video appointment